Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status

Abstract

Stratification based on N-myc amplification into new A1 and A3 treatment protocols is of significant clinical importance. Regimen A3 was well tolerated and showed an improvement in clinical results in stage 4 patients with N-myc amplified more than 10-fold.